Change Makers: Stéphane Bancel on Revolutionizing Medicine

The CEO of Moderna speaks with WebMD CMO John Whyte, MD, MPH, about the potential of mRNA technology and much more.

Related Keywords

Boston ,Massachusetts ,United States ,France ,Bancel ,Rhôalpes ,French ,John Whyte ,Chevalier Knight ,Genentech ,Amgen ,Change Makers ,Im Dr John Whyte ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Biologic Therapy ,Immunotherapeutic Targeting ,Cancer Staging ,Medical Innovations ,Nnovations In Medicine ,Cancer ,Alignant Neoplasia ,Arcinoma ,Liquid Biopsy ,Luid Biopsy ,Luid Phase Biopsy ,Cancer Blood Test ,Ancer Saliva Test ,Lood B ,